UPDATE: JPMorgan Downgrades Medtronic, Inc. (MDT) to Neutral, Removes from Analyst Focus List

December 17, 2021 3:40 AM EST Send to a Friend
(Updated - December 17, 2021 4:45 AM EST)

JPMorgan analyst Robbie Marcus downgraded Medtronic, Inc. (NYSE: MDT) from Overweight ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login